RNAV8 Bio is a stealth-mode company that focuses on engineering and designing large RNAs to treat chronic and acute, pre-cancerous diseases.
RNAV8 Bio has raised $4.4M in total funding. The most recent round was Grant. The last funding was announced in September 2026.
RNAV8 Bio's investors include Advanced Research Projects Agency for Health.
RNAV8 Bio is headquartered in Laguna Niguel, United States.
RNAV8 Bio is a stealth-mode company that focuses on engineering and designing large RNAs to treat chronic and acute, pre-cancerous diseases.
RNAV8 Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RNAV8 Bio — Funding & Investors." VCBacked, September 1, 2026, https://www.vcbacked.co/company/rnav8-bio. Accessed October 2, 2026.
VCBacked. (2026). RNAV8 Bio — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/rnav8-bio
{{cite web |title=RNAV8 Bio — Funding & Investors |url=https://www.vcbacked.co/company/rnav8-bio |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated